Healthcare-associated Infections

Print

Healthcare and Infection Control Gateway

This page provides guidance to state health agencies on controlling and responding to infectious disease risks in healthcare settings. It includes resources from state, territorial, and federal partners.

Click on each of the four categories in the image below to access the materials.  

Infection Control Resources Banner

GAO Report: Antibiotics: Antibiotic Resistance: More Information Needed to Oversee Use of Medically Important Drugs in Food Animals
Antibiotic-resistant bacteria are one of the biggest threats to global health, sickening an estimated 2 million people in the United States each year. There is strong evidence that some resistance in bacteria is caused by antibiotic use in food animals (cattle, poultry, swine). A report recently published by the United States Government Accountability Office updates previous data from a 2011 report addressing antibiotic use and gaps in data collection.

FDA Medical Countermeasures Initiative (MCMi) Fiscal Year 2016 Program Update Available
The Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA), enacted in 2013, requires FDA to issue an annual report detailing its medical countermeasure activities. This report responds to that requirement for fiscal year (FY) 2016 (Oct. 1, 2015 - Sept. 30, 2016).

Recap: Hill Briefing on Antibiotic Resistance
The Congressional Hill Briefing event hosted by IDSA on March 7, in collaboration with the U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR) and with support from several S-FAR member organizations, released Faces of Antimicrobial Resistance—the important and personal stories of patients and their families who battle the threat of antibiotic resistance every day.

CDC Study: Nearly 40% of VA Outpatient Antibiotics Not Needed
In May 2016, researchers from the Centers for Disease Control and Prevention (CDC) found that about a third of all oral antibiotics prescribed in US outpatient settings were inappropriate for acute respiratory infections (sinusitis, pharyngitis, bronchitis, and pneumonia). New research has determined that this problem also extends to government clinics. Investigators with the Providence Veteran’s Affairs (VA) Medical Center in Providence, RI, found inappropriate prescription rates in the hospital’s outpatient primary care department was 38.4% as compared to 34.2% in the CDC study.

Candida auris Interim Recommendations for Healthcare Facilities and Laboratories
Candida auris is an emerging fungus that presents a serious global health threat. Healthcare facilities in several countries have reported that C. auris has caused severe illness in hospitalized patients. Some strains of Candida auris are resistant to all three major classes of antifungal drugs. This type of multidrug resistance has not been seen before in other species of Candida.

 

« Learn more about ASTHO's infectious disease program